During the past decade, Arch Medical Services, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arch Medical Services, Inc." #1 sponsor was "US Oncology Research" with 3 trials, followed by "Abbott" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Point Therapeutics" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arch Medical Services, Inc." #1 collaborator was "Sanofi" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "US Oncology Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Arch Medical Services, Inc." are "Breast Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials), "Carcinoma, Non-Small Cell Lung" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Arch Medical Services, Inc." in a lesser frequency.

Most popular intervention types in "Arch Medical Services, Inc." are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "ABT-510 - Thrombospondin-1 Mimetic" (1 trials), "Cytoxan" (1 trials) and "Denileukin diftitox" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arch Medical Services, Inc." are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Arch Medical Services, Inc.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Arch Medical Services, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Arch Medical Services, Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".